Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Predictive factors of esophageal stenosis associated with tumor regression in radiation therapy for locally advanced esophageal cancer.

Atsumi K, Shioyama Y, Nakamura K, Nomoto S, Ohga S, Yoshitake T, Nonoshita T, Ueda M, Hirata H, Honda H.

J Radiat Res. 2010;51(1):9-14. Epub 2009 Oct 3.

2.

Esophageal stenosis associated with tumor regression in radiotherapy for esophageal cancer: frequency and prediction.

Atsumi K, Shioyama Y, Arimura H, Terashima K, Matsuki T, Ohga S, Yoshitake T, Nonoshita T, Tsurumaru D, Ohnishi K, Asai K, Matsumoto K, Nakamura K, Honda H.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1973-80. doi: 10.1016/j.ijrobp.2011.01.047. Epub 2011 Apr 7.

PMID:
21477944
3.

[Radiation stenosis and fistula formation developed after iridium-192 high-dose-rate intracavitary radiation boost therapy for carcinoma of the esophagus].

Onishi H, Ogata H, Uchiyama G, Yamaguchi M, Toyama K, Koizumi K, Monzawa S, Oba H, Kachi K, Araki T, et al.

Nihon Igaku Hoshasen Gakkai Zasshi. 1993 Feb 25;53(2):210-9. Japanese.

PMID:
8488104
4.

Concomitant chemotherapy and external radiotherapy plus brachytherapy for locally advanced esophageal cancer: results of a retrospective multicenter study.

Tessa M, Rotta P, Ragona R, Sola B, Grassini M, Nassisi D, Sciacero P, Airoldi M, Filippi A, Gianello L, De Angelis C, Ozzello F, Trotti AB, Ricardi U, Sannazzari GL.

Tumori. 2005 Sep-Oct;91(5):406-14.

PMID:
16459637
5.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.

PMID:
15380576
6.

Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy.

Valencia Julve J, Alonso Orduña V, Escó Barón R, López-Mata M, Méndez Villamón A.

Clin Transl Oncol. 2006 Jan;8(1):22-30.

PMID:
16632436
7.

Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.

Zhang Z, Liao Z, Jin J, Ajani J, Chang JY, Jeter M, Guerrero T, Stevens CW, Swisher S, Ho L, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):656-64.

PMID:
15708243
8.

Malignant tracheoesophageal fistula in patients with esophageal cancer.

Gschossmann JM, Bonner JA, Foote RL, Shaw EG, Martenson JA Jr, Su J.

Cancer. 1993 Sep 1;72(5):1513-21.

9.

Clinical outcomes and prognostic factors for patients with early esophageal squamous cell carcinoma treated with definitive radiation therapy alone.

Ishikawa H, Sakurai H, Yamakawa M, Saito Y, Nakayama Y, Kitamoto Y, Okamoto M, Harada K, Hasegawa M, Nakano T.

J Clin Gastroenterol. 2005 Jul;39(6):495-500.

PMID:
15942435
10.

Esophageal cancer: outcomes of surgery, neoadjuvant chemotherapy, and three-dimension conformal radiotherapy.

Fréchette E, Buck DA, Kaplan BJ, Chung TD, Shaw JE, Kachnic LA, Neifeld JP.

J Surg Oncol. 2004 Aug 1;87(2):68-74.

PMID:
15282698
11.

Clinical and dosimetric predictors of radiation-induced esophageal toxicity.

Maguire PD, Sibley GS, Zhou SM, Jamieson TA, Light KL, Antoine PA, Herndon JE 2nd, Anscher MS, Marks LB.

Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):97-103.

PMID:
10477012
12.

Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.

Caudell JJ, Schaner PE, Meredith RF, Locher JL, Nabell LM, Carroll WR, Magnuson JS, Spencer SA, Bonner JA.

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):410-5. doi: 10.1016/j.ijrobp.2008.04.048. Epub 2008 Jul 16.

PMID:
18635320
13.
14.
15.

Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer.

Di Fiore F, Lecleire S, Pop D, Rigal O, Hamidou H, Paillot B, Ducrotté P, Lerebours E, Michel P.

Am J Gastroenterol. 2007 Nov;102(11):2557-63. Epub 2006 Aug 4.

PMID:
17680847
16.

[Analysis of locally controlled esophageal carcinomas treated with radiotherapy].

Gotoh Y, Yamada S, Takai Y, Nemoto K, Ogawa Y, Hoshi A, Ariga H, Sakamoto K.

Nihon Igaku Hoshasen Gakkai Zasshi. 1996 May;56(6):418-25. Japanese.

PMID:
8710466
17.

Reduction in acute morbidity using hypofractionated intensity-modulated radiation therapy assisted with a fluoroscopic real-time tumor-tracking system for prostate cancer: preliminary results of a phase I/II study.

Kitamura K, Shirato H, Shinohara N, Harabayashi T, Onimaru R, Fujita K, Shimizu S, Nonomura K, Koyanagi T, Miyasaka K.

Cancer J. 2003 Jul-Aug;9(4):268-76.

PMID:
12967137
18.

Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer.

Lee SW, Choi EK, Lee JS, Lee SD, Suh C, Kim SW, Kim WS, Ahn SD, Yi BY, Kim JH, Noh YJ, Kim SS, Koh Y, Kim DS, Kim WD.

Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):996-1004.

PMID:
12829135
19.

Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy.

Kang SY, Han JH, Lee KJ, Choi JH, Park JI, Kim HI, Lee HW, Jang JH, Park JS, Kim HC, Kang S, Oh YT, Chun M, Kim JH, Sheen SS, Lim HY.

Clin Cancer Res. 2007 Jul 15;13(14):4146-53.

20.

Outcome of patients receiving photodynamic therapy for early esophageal cancer.

Corti L, Skarlatos J, Boso C, Cardin F, Kosma L, Koukourakis MI, Giatromanolaki A, Norberto L, Shaffer M, Beroukas K.

Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):419-24.

PMID:
10802369

Supplemental Content

Support Center